Perrigo Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Drug Facts

Manufacturer
Dispensing Solutions, Inc. | PSS World Medical, Inc.
Effective date
2013-07-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:36:12

Key Label Information

Active Ingredients And Purpose

Active ingredient (in each extended release tablet)

Cetirizine HCl 5 mg Pseudoephedrine HCl 120 mg

Purpose

Antihistamine Nasal Decongestant

Uses

Uses

• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat • nasal congestion • reduces swelling of nasal passages • temporarily relieves sinus congestion and pressure • temporarily restores freer breathing through the nose

Warnings

Warnings

Directions And Dosage

Directions

• do not break or chew tablet; swallow tablet whole adults and children 12 years and over take 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours. adults 65 years and over ask a doctor children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Other Label Information

Other information

• store between 20° to 25°C (68° to 77°F)

Inactive ingredients

colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, yellow iron oxide

Questions or comments?

1-800-719-9260

Principal Display Panel

Compare to Zyrtec-D® active ingredients Original Prescription Strength Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets, 5mg/120mg Antihistamine/Nasal Decongestant Allergy & Congestion 12 Hour Relief of: Sneezing Itchy, Watery Eyes Runny Nose Itchy Throat or Nose Sinus Pressure Nasal Congestion Indoor & Outdoor Allergies Actual Size NDC 68258-8907-02

Products

NDC Codes

Ingredients

Complete SPL Sections

Active ingredient (in each extended release tablet)

OTC - ACTIVE INGREDIENT SECTION

Cetirizine HCl 5 mg Pseudoephedrine HCl 120 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine Nasal Decongestant

Uses

INDICATIONS & USAGE SECTION

• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat • nasal congestion • reduces swelling of nasal passages • temporarily relieves sinus congestion and pressure • temporarily restores freer breathing through the nose

Warnings

WARNINGS SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

• do not break or chew tablet; swallow tablet whole adults and children 12 years and over take 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours. adults 65 years and over ask a doctor children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Other information

STORAGE AND HANDLING SECTION

• store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, yellow iron oxide

Questions or comments?

OTC - QUESTIONS SECTION

1-800-719-9260

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Compare to Zyrtec-D® active ingredients Original Prescription Strength Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets, 5mg/120mg Antihistamine/Nasal Decongestant Allergy & Congestion 12 Hour Relief of: Sneezing Itchy, Watery Eyes Runny Nose Itchy Throat or Nose Sinus Pressure Nasal Congestion Indoor & Outdoor Allergies Actual Size NDC 68258-8907-02

Source Document

Official SPL XML cached by FDA.report · DailyMed PDF

XML object
dailymed/89d33c73-ad56-43e1-b1a8-8bd98699c31d/2f0453e0-6c62-4ee0-94d8-5c354adb562d.xml
XML SHA-256
6ad25e2e0004854699a69b0ebb8a2bc4298655550dcd91e5255af154d5e5d43c
XML bytes
30956

Legacy File Index

FolderFileDate
otc2f0453e0-6c62-4ee0-94d8-5c354adb562d.xml2013-07-18
otcNDC 68258-8907-02------PERRIGO.jpg2013-07-18